Elmind Capital, LP
35 holdingsFiling period: 2026-06-30Current AUM: $348.9Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | COGT | Cogent Biosciences Inc | 1.17M | $45.3M | $36.3M | 10.41% | -- | 2026-06-30 |
| 2 | SNDX | Syndax Pharmaceuticals Inc | 1.85M | $40.5M | $25.3M | 7.26% | -- | 2026-06-30 |
| 3 | CLDX | Celldex Therapeutics Inc New | 990.0K | $36.8M | $29.8M | 8.54% | +125.0K | 2026-06-30 |
| 4 | RLAY | Relay Therapeutics Inc | 1.47M | $27.4M | $26.9M | 7.71% | +928.3K | 2026-06-30 |
| 5 | PCVX | Vaxcyte Inc | 452.3K | $26.3M | $28.1M | 8.04% | +135.8K | 2026-06-30 |
| 6 | VERA | Vera Therapeutics Inc | 436.5K | $18.7M | $13.5M | 3.88% | -45,982 | 2026-06-30 |
| 7 | — | Pharvaris N V | 525.8K | $18.2M | $18.2M | 5.21% | +50.0K | 2026-06-30 |
| 8 | VRDN | Viridian Therapeutics Inc | 984.9K | $18.1M | $24.3M | 6.96% | +450.0K | 2026-06-30 |
| 9 | CTMX | Cytomx Therapeutics Inc. | 4.55M | $17.1M | $10.6M | 3.05% | -- | 2026-06-30 |
| 10 | TVTX | Travere Therapeutics Inc | 292.6K | $16.6M | $14.7M | 4.23% | +115.0K | 2026-06-30 |
| 11 | LEGN | Legend Biotech Corp | 570.6K | $16.5M | $12.3M | 3.54% | -- | 2026-06-30 |
| 12 | BEAM | Beam Therapeutics Inc | 476.3K | $16.3M | $13.0M | 3.72% | -- | 2026-06-30 |
| 13 | CGEM | Cullinan Therapeutics Inc | 690.0K | $12.6M | $10.4M | 2.97% | +160.0K | 2026-06-30 |
| 14 | NRIX | Nurix Therapeutics Inc | 460.0K | $11.2M | $12.3M | 3.53% | -- | 2026-06-30 |
| 15 | KRYS | Krystal Biotech Inc | 22.0K | $8.2M | $7.3M | 2.10% | -- | 2026-06-30 |
| 16 | UTHR | United Therapeutics Corp Del | 15.0K | $8.1M | $9.0M | 2.57% | -- | 2026-06-30 |
| 17 | SMMT | Summit Therapeutics Inc | 493.8K | $7.2M | $7.9M | 2.27% | -- | 2026-06-30 |
| 18 | INSM | Insmed Inc | 65.0K | $6.9M | $7.3M | 2.10% | -- | 2026-06-30 |
| 19 | BCRX | Biocryst Pharmaceuticals Inc | 520.0K | $5.2M | $4.4M | 1.26% | -480,000 | 2026-06-30 |
| 20 | MBX | Mbx Biosciences Inc | 91.0K | $5.0M | $5.1M | 1.46% | -120,000 | 2026-06-30 |
| 21 | PTGX | Protagonist Therapeutics Inc | 38.0K | $4.7M | $5.5M | 1.58% | -- | 2026-06-30 |
| 22 | — | Urogen Pharma Ltd | 120.0K | $4.4M | $4.4M | 1.27% | -100,000 | 2026-06-30 |
| 23 | DBVT | Dbv Technologies S A | 265.0K | $4.3M | $2.5M | 0.72% | -- | 2026-06-30 |
| 24 | ALMS | Alumis Inc | 130.0K | $3.7M | $875K | 0.25% | -- | 2026-06-30 |
| 25 | SUPN | Supernus Pharmaceuticals | 70.0K | $3.3M | $2.9M | 0.84% | +50.0K | 2026-06-30 |
← Scroll →
Page 1 of 2